CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-22 | Brown Dennis M Chief Scientifc Officer | Grant or award · Options (Right to Buy) | +60,000 | 60,000 | ||
| 2020-09-15 | Praill Anthony Scott Chief Financial Officer | Grant or award · Options (Right to Buy) | +606,557 | 606,557 | ||
| 2020-09-15 | Liatos John SVP, Business Development | Grant or award · Options (Right to Buy) | +506,647 | 506,647 | ||
| 2020-09-15 | Brown Dennis M Chief Scientific Officer | Grant or award · Options (Right to Buy) | +87,437 | 87,437 | ||
| 2020-09-15 | Zarrabian Saiid President and CEO | Grant or award · Options (Right to Buy) | +2,715,004 | 2,715,004 | ||
| 2020-09-15 | HOFFMAN ROBERT Director | Grant or award · Options (Right to Buy) | +120,000 | 120,000 | ||
| 2020-09-15 | TOTH ROBERT JOSEPH JR Director | Grant or award · Options (Right to Buy) | +120,000 | 120,000 | ||
| 2020-09-15 | Murphy Keith Director | Grant or award · Options (Right to Buy) | +120,000 | 120,000 | ||
| 2020-09-15 | Johnson Laura L. Director | Grant or award · Options (Right to Buy) | +120,000 | 120,000 | ||
| 2020-08-19 | Liatos John SVP, Business Development | Purchase | +196,750 | 196,750 | ||
| 2020-08-19 | Murphy Keith Director | Purchase | +181,010 | 181,010 | ||
| 2020-06-30 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,474 | ||
| 2020-06-30 | Cranston Lynda Sarah Director | Other disposition | −8 | 332 | ||
| 2020-06-30 | Bell John K Director | Other acquisition | +29 | 9,817 | ||
| 2020-06-30 | TOTH ROBERT JOSEPH JR Director | Other acquisition | +8 | 1,214 | ||
| 2020-06-30 | Brown Dennis M Chief Scientific Officer | Other acquisition | +17 | 6,011 | ||
| 2020-06-26 | Praill Anthony Scott Chief Financial Officer | Grant or award · Option (Right to Buy) | +57,170 | 108,366 | ||
| 2020-06-26 | Cranston Lynda Sarah Director | Grant or award · Option (Right to Buy) | +39,567 | 75,000 | ||
| 2020-06-26 | Bell John K Director | Grant or award · Options (Right to Buy) | +39,567 | 75,000 | ||
| 2020-06-26 | TOTH ROBERT JOSEPH JR Director | Grant or award · Option (Right to Buy) | +39,567 | 75,000 |
Page 5 of 18 · 357 trades